Infective dose of foodborne pathogens in volunteers: A review

被引:224
作者
Kothary, MH [1 ]
Babu, US [1 ]
机构
[1] US FDA, Ctr Food Safety & Appl Nutr, Div Virulence Assessment HFS327, Washington, DC 20204 USA
关键词
D O I
10.1111/j.1745-4565.2001.tb00307.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Risk assessment and impact of foodborne pathogens on the health of different populations was one of the goals identified in the Presidential Food Safety Initiative three-year plan. This entailed estimation of dose-response relationship for foodborne pathogens to humans, either by feeding studies or from outbreak. For certain pathogens, such as Listeria monocytogenes and Escherichia coli O157. H7, there are no feeding studies due to ethical reasons, and the results from outbreaks are normally used to estimate the infectious dose. The focus of this review is to compile dose-response information in volunteers for several foodborne pathogens including Salmonella, Shigella spp., Campylobacter jejuni, Vibrio spp., Escherichia coli, Cryptosporidium parvum and Entamoeba coli. The infectious dose for different serovars of Salmonella and strains of E. coli was quite large (> 10(5) organisms), while the infectious dose for some Shigella spp. seemed to be as low as less than 10 organisms. Toxigenic V, cholerae (O1 and O139 serotypes) were infective at a dose of 10(4) organisms, a non-O1 strain was infective at a much higher dose (10(6) organisms). C. jejuni, C. parvum and Entamoeba coli appeared to have infectious doses as low as 500 organisms, 10 oocysts, and 1 cyst, respectively. The infectious dose and the dose response are dependent upon the strains used, and the age and physical condition of the individuals, and can therefore show wide variations. In addition, since many of the volunteer studies are carried out by feeding the organisms in a nonfood matrix after neutralizing the stomach acidity, results obtained may not reflect the true dose response.
引用
收藏
页码:49 / 73
页数:25
相关论文
共 71 条
  • [1] AISO K, 1963, ANN REP I FOOD MICRO, V15, P34
  • [2] BESSERWIEK JW, 1995, MMWR-MORBID MORTAL W, V45, P783
  • [3] PREVENTION OF SHIGELLOSIS BY A SALMONELLA-TYPHI-SHIGELLA SONNEI BIVALENT VACCINE
    BLACK, RE
    LEVINE, MM
    CLEMENTS, ML
    LOSONSKY, G
    HERRINGTON, D
    BERMAN, S
    FORMAL, SB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) : 1260 - 1265
  • [4] PROTECTIVE EFFICACY IN HUMANS OF KILLED WHOLE-VIBRIO ORAL CHOLERA VACCINE WITH AND WITHOUT THE B-SUBUNIT OF CHOLERA-TOXIN
    BLACK, RE
    LEVINE, MM
    CLEMENTS, ML
    YOUNG, CR
    SVENNERHOLM, AM
    HOLMGREN, J
    [J]. INFECTION AND IMMUNITY, 1987, 55 (05) : 1116 - 1120
  • [5] EXPERIMENTAL CAMPYLOBACTER-JEJUNI INFECTION IN HUMANS
    BLACK, RE
    LEVINE, MM
    CLEMENTS, ML
    HUGHES, TP
    BLASER, MJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) : 472 - 479
  • [6] BLASER MJ, 1982, REV INFECT DIS, V4, P1096
  • [7] RESPONSE OF MAN TO INFECTION WITH VIBRIO-CHOLERAE .1. CLINICAL, SEROLOGIC, AND BACTERIOLOGIC RESPONSES TO A KNOWN INOCULUM
    CASH, RA
    MUSIC, SI
    LIBONATI, JP
    SNYDER, MJ
    WENZEL, RP
    HORNICK, RB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (01) : 45 - 52
  • [8] Cryptosporidium parvum: Intensity of infection and oocyst excretion patterns in healthy volunteers
    Chappell, CL
    Okhuysen, PC
    Sterling, CR
    DuPont, HL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) : 232 - 236
  • [9] Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C.: Parvum serum immunoglobulin G
    Chappell, CL
    Okhuysen, PC
    Sterling, CR
    Wang, C
    Jakubowski, W
    Dupont, HL
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (01) : 157 - 164
  • [10] Cohen MB, 1999, INFECT IMMUN, V67, P6346